|
Evaluation and Natural History of Children with Cancer and AIDS Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Evaluation and Natural History of Children with Cancer and AIDS conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Evaluation and Natural History of Children with Cancer and AIDS Clinical research trials and Evaluation and Natural History of Children with Cancer and AIDS healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Evaluation and Natural History of Children with Cancer and AIDS. Evaluation and Natural History of Children with Cancer and AIDS Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Evaluation and Natural History of Children with Cancer and AIDS clinical trial. Participants typically obtain the most effective healthcare available for their Evaluation and Natural History of Children with Cancer and AIDS condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation and Natural History of Children with Cancer and AIDS Evaluation and Natural History of Children with Cancer and AIDS
Evaluation and Natural History of Children with Cancer and AIDS
For Condition: Acquired Immunodeficiency Syndrome,Cancer,HIV Infections,Leukemia,Lymphoma
Status: Completed
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.
Details: This protocol will enable the Pediatric Branch to follow selected children with cancer or HIV infection who are not immediately eligible for protocol enrollment but who are likely, within the next year, to become candidates for protocol entry. It will also enable the Pediatric Branch to follow children who present with either clinical findings that constitute important educational experiences for the NCI trainees or who have unique or unusual medical problems that are likely to benefit from the research expertise of the NCI.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Children with cancer (or a precancer syndrome) or HIV infection, between the age(s) of 3 months to 30 years, who are evaluated by the Pediatric Branch and are found to be not immediately eligible for an ongoing protocol but are likely to become a candidate for a future protocol. Children with cancer (or a precancer syndrome) or HIV infection, who present with disease manifestations of special interest to Pediatric Branch investigators, because they are likely to shed light on disease. Patients who, when evaluated by the Branch, are determined to likely never become eligible for a Pediatric Branch protocol are not eligible for this protocol. No patients younger than 3 months of age or older than 30 years of age are eligible for this protocol.
Total Enrollment: 110
Location and Contact Information:
National Cancer Institute (NCI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 950025; 95-C-0025
Study Start Date: November 1, 1994
Record last reviewed: October 1, 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001424
Other Acquired Immunodeficiency Syndrome Studies:
1. Vaccine for Metastatic Cancer
2. Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
3. Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines
4. Evaluation and Natural History of Children with Cancer and AIDS
5. Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
Related Studies:
Other Acquired Immunodeficiency Syndrome Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation and Natural History of Children with Cancer and AIDS
|
|
|
|
|
|
|
|